Index Ventures spins off life sciences portfolio into Medicxi Ventures
Index Ventures, an early investor in technology hits like Skype and Dropbox, is spinning off its biotech portfolio into a new $1 billion business, with backing from drug giants GlaxoSmithKline and Johnson & Johnson.
2 February 2016•2 mins read
